ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 168 filers reported holding ACCELERON PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $11,527,000 | -30.5% | 90,100 | -38.9% | 0.03% | -34.0% |
Q3 2020 | $16,587,000 | +40.7% | 147,400 | +19.2% | 0.05% | +34.3% |
Q2 2020 | $11,785,000 | +179.0% | 123,700 | +163.2% | 0.04% | +118.8% |
Q1 2020 | $4,224,000 | +860.0% | 47,000 | +466.3% | 0.02% | +1500.0% |
Q4 2019 | $440,000 | -77.7% | 8,300 | -83.4% | 0.00% | -80.0% |
Q3 2019 | $1,972,000 | -28.7% | 49,900 | -25.9% | 0.01% | -28.6% |
Q2 2019 | $2,765,000 | -15.5% | 67,300 | -4.3% | 0.01% | -12.5% |
Q1 2019 | $3,274,000 | – | 70,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,080,113 | $50,301,000 | 4.98% |
Foresite Capital Management II, LLC | 188,602 | $8,783,000 | 3.96% |
Artal Group S.A. | 1,650,000 | $76,841,000 | 3.14% |
Foresite Capital Management III, LLC | 254,923 | $11,872,000 | 3.09% |
Asymmetry Capital Management, L.P. | 30,125 | $1,403,000 | 2.34% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,255,174 | $58,453,000 | 2.24% |
QVT Financial LP | 190,977 | $8,894,000 | 2.24% |
SECTORAL ASSET MANAGEMENT INC | 269,396 | $12,546,000 | 1.51% |
Novo Holdings A/S | 198,261 | $9,233,000 | 1.37% |
FARALLON CAPITAL MANAGEMENT LLC | 2,375,000 | $110,604,000 | 0.83% |